학술논문

A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)
Document Type
Article
Source
In: Pediatric Blood and Cancer. (Pediatric Blood and Cancer, June 2024, 71(6))
Subject
Language
English
ISSN
15455017
15455009